The DFG-funded SFB/TRR 417 “Cellular Communication in the Stroma of Colorectal Cancer: From Pathophysiology to Clinical Translation” brings together leading researchers from Goethe University Frankfurt, Friedrich-Alexander-Universität Erlangen-Nürnberg, and the University of Freiburg, with associated partners at Georg-Speyer-Haus and Paul-Ehrlich-Institut. Established in October 2025, the consortium explores how interactions between cancer cells and the tumor microenvironment shape colorectal cancer progression and influence treatment response. By bridging basic research and clinical application, TRR 417 aims to uncover novel therapeutic strategies that improve patient outcomes. The consortium also focuses on training the next generation of researchers and clinician scientists and strengthening long-term collaborative cancer research across Germany.

SFB/TRR 417

Org chart

Teams

Offices

SFB/TRR 417

Org chart

Teams

Offices

Related companies